-
Fmoc-3-(2-Naphthyl)-L-alanine 112883-43-9
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Awọn ohun elo aise |Pharmaceutical Intermediates Reagents |Imuniloji |Peptide kolaginni |Amino acid jara |Fmoc-3- (2-Naphthyl) -L-alanine |CAS: 112883-43-9 |C28H23NO4
-
Fmoc-Trp (Boc) -OH 143824-78-6
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Awọn ohun elo aise |Pharmaceutical Intermediates Reagents |Imuniloji |Peptide kolaginni |Fmoc-Trp (Boc)-OH |CAS: 143824-78-6 |C31H30N2O6
-
Fmoc-L-Leucine 35661-60-0
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Awọn ohun elo aise |Pharmaceutical Intermediates Reagents |Imuniloji |Peptide kolaginni |Amino acid jara |Fmoc-L-Leucine |CAS: 35661-60-0 |C21H23NO4
-
Fmoc-D-leucine 114360-54-2
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Awọn ohun elo aise |Pharmaceutical Intermediates Reagents |Imuniloji |Peptide kolaginni |Amino acid jara |Fmoc-D-leucine |CAS: 114360-54-2 |C21H23NO4
-
![N6-[(1,1-Dimethylethoxy) carbon]-N2-[(9H-fluoren-9-ylmethoxy) carbon]-2-methyl-L-lysine 1202003-49-3](https://www.yisunbio.com/uploads/281.jpg)
N6-[(1,1-Dimethylethoxy) carbon]-N2-[(9H-fluoren-9-ylmethoxy) carbon]-2-methyl-L-lysine 1202003-49-3
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Awọn ohun elo aise |Pharmaceutical Intermediates Reagents |Imuniloji |Peptide kolaginni |N6-[(1,1-Dimethylethoxy) carbon] -N2-[(9H-fluoren-9-ylmethoxy) carbon] -2-methyl-L-lysine |CAS: 1202003-49-3 |C27H34N2O6
-
![O-[2-[(1,1-Dimethylethoxy) carbonyl] amino] ethyl] -N-[(9H-fluoren-9-ylmethoxy) carbonyl]-L-tyrosine 1013883-02-7](https://www.yisunbio.com/uploads/29-300x115.jpg)
O-[2-[(1,1-Dimethylethoxy) carbonyl] amino] ethyl] -N-[(9H-fluoren-9-ylmethoxy) carbonyl]-L-tyrosine 1013883-02-7
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Awọn ohun elo aise |Pharmaceutical Intermediates Reagents |Imuniloji |Peptide kolaginni |O-[2-[(1,1-Dimethylethoxy) carbon] amino] ethyl] -N-[(9H-fluoren-9-ylmethoxy) carbon]-L-tyrosine |CAS: 1013883-02-7 |C31H34N2O7
-
Hippuric acid 495-69-2
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Awọn ohun elo aise |Pharmaceutical Intermediates Reagents |Imuniloji |Peptide kolaginni |Hippuric acid |CAS: 495-69-2 |C9H9NO3
-
Valsartan 137862-53-4
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Kemikali Reagents |Kemikali aise ohun elo |Ise elegbogi agbedemeji |Ẹjẹ inu ọkan |Haipatensonu itọju |Valsartan Intermediates |Valsartan |CAS: 137862-53-4 |C24H29N5O3
-
L-Valine methyl ester hydrochloride 6306-52-1
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Kemikali Reagents |Kemikali aise ohun elo |Ise elegbogi agbedemeji |Ẹjẹ inu ọkan |Valsartan Intermediates |L-Valine methyl ester hydrochloride |CAS: 6306-52-1 |C6H13NO2.HCl
-
![N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester hydrochloride 482577-59-3](https://www.yisunbio.com/uploads/34.jpg)
N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester hydrochloride 482577-59-3
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Kemikali Reagents |Kemikali aise ohun elo |Ise elegbogi agbedemeji |Ẹjẹ inu ọkan |Haipatensonu itọju |Valsartan Intermediates |N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester hydrochloride |CAS: 482577-59-3 |C20H22N2O2.HCl
-
Valsartan methyl ester 137863-17-3
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Kemikali Reagents |Kemikali aise ohun elo |Ise elegbogi agbedemeji |Ẹjẹ inu ọkan |Haipatensonu itọju |Valsartan Intermediates |N- (1-Oxopentyl) -N-[[2'- (1H-tetrazol-5-yl) [1,1'-biphenyl] -4-yl] methyl] -L-valine methyl ester |CAS: 137863-17-3 |C25H31N5O3
-
(S) -2,4-Dichloro-alpha-(chloromethyl) -benzenemethanol 126534-31-4
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Pharmaceutical Intermediates Reagents |Awon arun |Ẹkọ-ara |Luliconazole Intermediates |(S) -2,4-Dichloro-alpha-(chloromethyl) -benzenemethano |CAS: 126534-31-4 |C8H7Cl3O